The immune system can recognize and kill cancer cells. One cell type that excels at this is the cytotoxic T cell, or CD8+ T cell. CD8+ T cells are a central component of tu...

This research explores the intricate relationship between proteins in the tumor environment, known as the extracellular matrix (ECM), and the behavior of natural killer (NK...

T cell immunotherapies, which harness the power of a patient’s own immune system to eliminate tumor cells, are becoming an increasingly promising treatment avenue for mel...

Melanoma is the deadliest type of skin cancer. Although it mostly affects people with lighter skin, those with darker skin, including Asian, Asian American, and Pacific Isl...

The use of artificial intelligence (AI) in dermatology is becoming increasingly prevalent and advancing rapidly. Current research has demonstrated its great potential in id...

Melanoma is an aggressive and potentially deadly form of skin cancer that often resists standard treatments. Recent advances in immunotherapy—using the body’s own immun...

Surgical removal of early melanomas has a high survival rate of 98%, but metastasis, the spread of cancer to other sites in the body, brings that survival rate down to 50%....

Primary melanoma tumors can have small nests of cancer cells called “microsatellites” neighboring the primary tumor. The presence of microsatellitosis has been ...